Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05123729 · ClinicalTrials.gov registry record
Leveraging Social Innovation and Community-Engagement to Reduce Disparities in Outbreak Control Outcomes
A clinical trial of Outbreak Investigation, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 546
- Enrollment target
- 1
- Study location
NCT05123729: Completed study of Outbreak Investigation, sponsored by Wake Forest University Health Sciences.
NCT05123729 is a study of Outbreak Investigation that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 546 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05123729, a study of Outbreak Investigation, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 546 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the impact of an intervention to increase viral transmission behaviors. The intervention will be developed through a crowdsourcing contest.
Primary Outcome
Number of participants enrolled as measured by enrollment log
Conditions Studied
Interventions
- BEHAVIORAL Crowdsourced campaign package
- BEHAVIORAL Rapid Response Teams
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2025-10-31 |
What the finished NCT05123729 record still lists
NCT05123729 is an observational study that tracks outcomes without assigning an intervention. The registered 546 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Outbreak Investigation appearing as the primary indexed condition, and to 2 interventions - of which Crowdsourced campaign package is the first listed.
NCT05123729 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05123729 about?
NCT05123729 is a clinical study titled "Leveraging Social Innovation and Community-Engagement to Reduce Disparities in Outbreak Control Outcomes". This study evaluates the impact of an intervention to increase viral transmission behaviors. The intervention will be developed through a crowdsourcing contest.
What is the current status of trial NCT05123729?
This trial is currently completed. The enrollment target is 546 participants. The study started on 2024-02-01. Estimated completion is 2025-10-31.
What conditions does trial NCT05123729 study?
This clinical trial studies the following conditions: Outbreak Investigation.
What interventions are being tested in trial NCT05123729?
The interventions under investigation include: Crowdsourced campaign package (BEHAVIORAL), Rapid Response Teams (BEHAVIORAL).
Who is sponsoring clinical trial NCT05123729?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05123729 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Outbreak Investigation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03572374 · 546 participants · NA
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
- NCT05937685 · 546 participants · NA
Reducing Blood Pressure in Patients With High Cardiovascular Risk
- NCT06416150 · 546 participants · NA
Reducing Urban Cervical Cancer Disparities
- NCT06850922 · 546 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI